Targeting RLIP with CRISPR/Cas9 controls tumor growth

Jyotsana Singhal(City Of Hope National Medical Center), Sharad S. Singhal(City Of Hope National Medical Center)

Carcinogenesis

May 14, 2020

10.1093/carcin/bgaa048

Cited by 22

Related Papers

2'-Hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma

|Carcinogenesis|2011|41

RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer

|PLoS ONE|2012|39

COH-SR4 Reduces Body Weight, Improves Glycemic Control and Prevents Hepatic Steatosis in High Fat Diet-Induced Obese Mice

|PLoS ONE|2013|28

2’-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer

|Oncotarget|2018|24